The University Group Diabetes Program. A statistician looks at the mortality results.

Suppr

超能文献

作者信息

Schor S

出版信息

JAMA. 1971 Sep 20;217(12):1671-5.

PMID:4937385

Abstract

摘要

相似文献

The University Group Diabetes Program. A statistician looks at the mortality results.

JAMA. 1971 Sep 20;217(12):1671-5.

The University Group Diabetes Program. A further statistical analysis of the mortality findings.

JAMA. 1971 Sep 20;217(12):1676-87.

The influence of diagnostic criteria on the mortality findings in the University Group Diabetic Programme study of diabetic therapy.诊断标准对大学组糖尿病计划糖尿病治疗研究中死亡率结果的影响。

Med J Aust. 1973 Mar 24;1(12):594-6. doi: 10.5694/j.1326-5377.1973.tb110572.x.

Effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes. IV. A preliminary report on phenoformin results.

JAMA. 1971 Aug 9;217(6):777-84.

A summary of criticisms of the findings and conclusions of the University Group Diabetes Program (UGDP).

Diabetes. 1972 Sep;21(9):976-9. doi: 10.2337/diab.21.9.976.

Effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes. VIII. Evaluation of insulin therapy: final report.

Diabetes. 1982 Nov;31 Suppl 5:1-81.

Tolbutamide study raises blood pressures.甲苯磺丁脲研究导致血压升高。

Nature. 1970 Dec 26;228(5278):1251-2. doi: 10.1038/2281251a0.

The crux of the UGDP. Spurious results and biologically inappropriate data analysis.

Diabetologia. 1980 Mar;18(3):179-85. doi: 10.1007/BF00251913.

Comments on the UGDP study.

Horm Metab Res. 1974;Suppl 4:188-91.

Editorials: Statistical problems in clinical trials: the UGDP study revisited.社论：临床试验中的统计学问题：对UGDP研究的重新审视

Am J Med. 1973 Dec;55(6):727-32. doi: 10.1016/0002-9343(73)90252-0.

引用本文的文献

The trials and tribulations of the University Group Diabetes Program 2: lessons and reflections.大学组糖尿病项目的艰难困苦2：经验教训与反思

J R Soc Med. 2019 Dec;112(12):503-511. doi: 10.1177/0141076819890263.

Efficacy and safety of insulin in type 2 diabetes: meta-analysis of randomised controlled trials.胰岛素治疗2型糖尿病的疗效与安全性：随机对照试验的荟萃分析

BMC Endocr Disord. 2016 Jul 8;16(1):39. doi: 10.1186/s12902-016-0120-z.

Jerome Cornfield's Bayesian approach to assessing interim results in clinical trials.杰罗姆·康菲尔德用于评估临床试验中期结果的贝叶斯方法。

J R Soc Med. 2016 Jan;109(1):27-35. doi: 10.1177/0141076815621243.

Dose-response relation between sulfonylurea drugs and mortality in type 2 diabetes mellitus: a population-based cohort study.磺脲类药物与2型糖尿病患者死亡率之间的剂量反应关系：一项基于人群的队列研究。

CMAJ. 2006 Jan 17;174(2):169-74. doi: 10.1503/cmaj.050748.

A rational approach to drug therapy of type 2 diabetes mellitus.2型糖尿病药物治疗的合理方法。

Drugs. 2000 Jul;60(1):95-113. doi: 10.2165/00003495-200060010-00006.

Sulphonylurea treatment of NIDDM patients with cardiovascular disease: a mixed blessing?磺脲类药物治疗患有心血管疾病的非胰岛素依赖型糖尿病患者：是福是祸？

Diabetologia. 1996 May;39(5):503-14. doi: 10.1007/BF00403296.

Informed consent, clinical research and the practice of medicine.知情同意、临床研究与医学实践。

Trans Am Clin Climatol Assoc. 1983;94:204-12.

Serum lipids and apoprotein composition (%) of the very low density lipoprotein (VLDL) fraction in two groups of diabetic patients: effects of oral as compared to insulin therapy.两组糖尿病患者极低密度脂蛋白（VLDL）部分的血清脂质和载脂蛋白组成（%）：口服治疗与胰岛素治疗的效果比较

Acta Diabetol Lat. 1980 Jul-Dec;17(3-4):225-8. doi: 10.1007/BF02581322.

The crux of the UGDP. Spurious results and biologically inappropriate data analysis.

Diabetologia. 1980 Mar;18(3):179-85. doi: 10.1007/BF00251913.

Hypoglycemic treatments and the fibrinolytic system in maturity-onset diabetes mellitus without thromboembolic manifestations.

Acta Diabetol Lat. 1983 Jan-Mar;20(1):63-70. doi: 10.1007/BF02629131.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验